In this Issue Last-Minute Rule Changes, Opt-Outs, Ahead of Colorado’s Psychedelics Program Launch Cybin’s Impressive 12-Month Data Overshadowed by Small N and Controversial Marketing Move
Now, let’s disaggregate those sentiment scores by investor type. More institutional-type investors, in red, have become more bullish since our last survey, with nearly half
Having abandoned two attempts at scheduling sets of psychedelics following pushback (as in the case of the five tryptamines and the earlier effort to schedule
Last-minute donations from Dr. Bronner’s ($100k), Elliot Cohen ($100k), Eliza Dushku ($100k), MAPS ($50k), and others could not push Question 4 over the line, with the Massachusetts
While Trump himself has been quiet on psychedelics, he demonstrated a ‘personal interest’ in fast-tracking Johnson & Johnson’s esketamine nasal spray product (Spravato) for use
Massachusetts looks set to reject Question 4, the only standalone psychedelic policy reform initiative to go before the electorate during this year’s polls. That means
What is Question 4? The only standalone psychedelic policy reform initiative to go before voters at this election is Massachusetts’ Question 4, which would legalise
With the end of election season in the United States less than a day away, psychedelics advocates in Massachusetts pulled out all the stops in
Beyond the direct psychedelic referenda in Massachusetts and some locales in Oregon, the reconstitution of the federal political landscape after tomorrow’s U.S. elections could also
I am a practicing psychiatrist, medical director, and assistant professor in psychiatry in Massachusetts. I also hold a PhD in the history of psychiatry, making